Literature DB >> 17361348

Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine.

Germán Morís, Renee Ribacoba, Carmen González.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17361348     DOI： 10.1007/s00415-006-0273-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Severe neurotoxicity caused by gemcitabine treatment.

Authors:  Finn Ole Larsen; Steen Werner Hansen
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

2.  Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia.

Authors:  P S Rangi; W J Partridge; E S Newlands; A D Waldman
Journal:  Neuroradiology       Date:  2005-07-05       Impact factor: 2.804

Review 3.  Neurological complications of radiotherapy and chemotherapy.

Authors:  F Keime-Guibert; M Napolitano; J Y Delattre
Journal:  J Neurol       Date:  1998-11       Impact factor: 4.849

4.  Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings.

Authors:  M T Russell; A S Nassif; E D Cacayorin; E Awwad; W Perman; F Dunphy
Journal:  Magn Reson Imaging       Date:  2001-01       Impact factor: 2.546

Review 5.  Posterior leukoencephalopathy syndrome.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2001-01       Impact factor: 2.401

6.  Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y.

Authors:  Elisabetta Donzelli; Maria Carfì; Mariarosaria Miloso; Alberto Strada; Stefania Galbiati; Martine Bayssas; Genevieve Griffon-Etienne; Guido Cavaletti; Maria Grazia Petruccioli; Giovanni Tredici
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 7.  Cisplatin-induced encephalopathy and seizures.

Authors:  N Steeghs; F E de Jongh; P A E Sillevis Smitt; M J van den Bent
Journal:  Anticancer Drugs       Date:  2003-07       Impact factor: 2.248

8.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245
  8 in total
  4 in total

Review 1.  Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

Authors:  Joan How; Margaret Blattner; Susan Fowler; Andrea Wang-Gillam; Suzanne E Schindler
Journal:  Neurologist       Date:  2016-11       Impact factor: 1.398

Review 2.  Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients.

Authors:  Eileen M Le; Monica E Loghin
Journal:  Curr Oncol Rep       Date:  2014-05       Impact factor: 5.075

3.  Posterior Reversible Encephalopathy Syndrome after a Variety of Combined Chemotherapies Containing Bevacizumab for Metastatic Colon Cancer.

Authors:  Eiichi Katada; Akira Mitsui; Shigeru Sasaki; Norihiko Uematsu; Chise Anan
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

4.  Oxaliplatin-Induced Tonic-Clonic Seizures.

Authors:  Ahmad K Rahal; Phu V Truong; K James Kallail
Journal:  Case Rep Oncol Med       Date:  2015-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.